CLBT
Cellebrite DI Ltd. trades as CLBT and has a market capitalization of $4.06 B, making it the #1584 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $475.68M, up 18.6% from the prior year and net income of $78.33M. This page tracks Cellebrite DI Ltd. through 319 SEC filings, with financial statements and metrics updated as new reports are filed.
Research snapshot
Updated
2026-07-09
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Next research step
Over the last 6 fiscal years Cellebrite DI Ltd.'s revenue grew from $171.85M to $475.68M, a compound annual growth rate of 18.5%. Net profit margin expanded from -1.1% to 16.5% over the same period - every figure below comes from the company's audited annual filings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-26 |
| Insider sale notice | 144 | 2026-05-21 |
| Insider sale notice | 144 | 2026-05-21 |
| Insider trade | 4 | 2026-05-19 |
| Insider sale notice | 144 | 2026-05-18 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
| Insider trade | 4 | 2026-05-14 |
First-Quarter ARR Growth of 21% and TTM Free Cash Flow Margin of 32%
Cellebrite Announces Participation in Upcoming Investor Conferences
Later that same morning, Cellebrite will host a live conference call and webcast to review the Company's financial results for the first quarter of 2026 and discuss its 2026 outlook. Relevant details include:
The largest companies sharing Cellebrite DI Ltd.'s SEC industry classification (services-prepackaged software).
Cellebrite DI Ltd. (CLBT) has a market capitalization of $4.06 B as of 2026-07-09, ranking #1584 among US-listed companies.
Cellebrite DI Ltd. reported revenue of $475.68M for fiscal year 2025, an increase of 18.6% year over year.
Yes. Cellebrite DI Ltd. reported net income of $78.33M in its latest fiscal year.